kvmb Chapter 592
Chapter 592
"Mr. Chen, because I have been diagnosed with breast cancer."
"The doctor's advice to me was to have surgery right away, but the cost of the surgery was something I couldn't afford."
"I heard that Pfizer acquired a new drug for treating breast cancer that can cure breast cancer without surgery. Do you think it's reliable?"
The middle-aged female audience member immediately expressed her problem.
Although her question was not suitable for this session and did not meet the requirements of this session.
This question is to let the audience tell Chen Xuan what diseases they hope to conquer, rather than asking him to evaluate the drugs of other pharmaceutical companies.
Given his current status, it is not appropriate for him to evaluate new drugs from other pharmaceutical companies.
After all, he is not a doctor, but the boss of a pharmaceutical company and a scientist who develops new drugs. It is naturally inappropriate to ask him to evaluate the drugs of other pharmaceutical companies.
If he fails to grasp the right balance, it will be easy for people to hype up the story as him maliciously attacking other pharmaceutical companies, and think that such evaluation is a form of suppression.
But the female audience had no choice. Apart from this channel, she could no longer find an opportunity to ask Chen Xuan for advice.
"Breast cancer? I didn't expect her to be so miserable."
"The cost of breast cancer surgery is indeed quite high. It's not about the money, but the fact that it has to be removed, which most people can't afford."
"My friend had advanced breast cancer and had to undergo surgery to remove it. After the surgery, her husband changed, and she ended up divorcing him in depression."
"Not to mention men, I can't stand it myself. I'm breaking down every day. If I had a choice, I would rather have conservative treatment than suffer this."
"I don't think so. Life is more important than anything else. It's just unsightly, but I can accept that. Of course, it would be best if there were better treatment, but if not, surviving is the most important thing."
"I've also heard of Pfizer's Alciran anti-cancer drug. I heard it can cure breast cancer without surgery. I wonder if that's true."
"How could this be fake? All the trial reports are out, and Pfizer's market value has skyrocketed by tens of billions of dollars. How could it be fake?"
"Pfizer made $120 billion this time by acquiring the formula, and then immediately saw its market value surge by tens of billions of dollars. It was a truly lucrative profit."
The issue of middle-aged female audiences has also aroused a lot of discussion.
The frequency of breast cancer being discovered is indeed increasing, perhaps due to the stressful pace of life or other lifestyle habits.
As a result, the number of new cases of breast cancer is increasing, and people around us are finding that patients with this disease are becoming more and more common, and they all know that this cancer is very scary.
But precisely because of this, the market for breast cancer is bound to be huge.
Now Pfizer has just acquired the anti-cancer drug Alciran, and its market value has skyrocketed by tens of billions of dollars.
In this situation, a breast cancer patient suddenly asked Chen Xuan about the Elshilan anti-cancer drug, which made everyone very curious.
They all wanted to know what he would think of the drug and whether he thought it would affect his company.
……
……
"Let's not discuss whether this new drug can cure breast cancer."
"Even though it can cure breast cancer, it's only in phase III clinical trials. According to normal procedures, it won't be available on the market for at least a year or two."
"Even if everything goes well, it will take more than a year or two for this drug to successfully enter the Chinese market. I don't know if it will be successful, but are you sure your body can last that long?"
Bingbing originally wanted to skip this topic to avoid making it inconvenient for Chen Xuan to answer.
However, Chen Xuan spoke before her.
"If your body can't bear it,"